NCT05517122View on ClinicalTrials.gov

Effect of Oral NAD+ Precursors Administration on Blood NAD+ Concentration in Healthy Adults

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

July 12, 2022

Primary Completion Date

November 24, 2022

Study Completion Date

November 24, 2022

Conditions
Healthy
Interventions
DIETARY_SUPPLEMENT

Nicotinamide (NAM)

500 mg a day

DIETARY_SUPPLEMENT

Nicotinamide Riboside (NR)

1000 mg a day

DIETARY_SUPPLEMENT

Nicotinamide Mono Nucleotide (NMN)

1000 mg a day

DIETARY_SUPPLEMENT

Microcrystalline cellulose

500 mg a day

Trial Locations (1)

1000

Nestlé Clinical Innovation Lab, Lausanne

All Listed Sponsors
lead

Société des Produits Nestlé (SPN)

INDUSTRY